Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Ultragenyx Pharmaceutical Inc. buy Jefferies Financial Group Inc.

Ultragenyx Pharmaceutical Inc.
Start price
€17.00
30.12.25 / 50%
Target price
€53.50
30.12.26
Performance (%)
33.29%
Price
?
08:33
Summary
This prediction is currently active. The BUY prediction by Jefferies_Financial_ for Ultragenyx Pharmaceutical Inc. has seen massive gains of 33.29%. This prediction currently runs until 30.12.26. The prediction end date can be changed by Jefferies_Financial_ at any time. Jefferies_Financial_ has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Ultragenyx Pharmaceutical Inc. 9.794% 9.794%
iShares Core DAX® -1.586% 5.028%
iShares Nasdaq 100 -4.148% -0.125%
iShares Nikkei 225® -6.302% 0.528%
iShares S&P 500 -3.225% 0.470%

Comments by Jefferies_Financial_ for this prediction

In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Prediction Buy
Perf. (%) 33.29%
Target price 53.500
Change
Ends at 30.12.26

Ultragenyx Pharmaceutical (NASDAQ:RARE) had its price target lowered by analysts at Jefferies Financial Group Inc. from $114.00 to $63.00. They now have a "buy" rating on the stock.
Ratings data for RARE provided by MarketBeat

Jefferies Financial Group Inc. 
0
Report Share
30.12.25